180 related articles for article (PubMed ID: 33209881)
1. Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial.
Sun HC; Zhu XD; Zhou J; Gao Q; Shi YH; Ding ZB; Huang C; Qiu SJ; Ren N; Shi GM; Sun J; Ye QH; Huang XW; Yang XR; Fan J
Ann Transl Med; 2020 Oct; 8(20):1301. PubMed ID: 33209881
[TBL] [Abstract][Full Text] [Related]
2. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Yuan G; Cheng X; Li Q; Zang M; Huang W; Fan W; Wu T; Ruan J; Dai W; Yu W; Chen M; Guo Y; Hu X; Chen J
Onco Targets Ther; 2020; 13():12683-12693. PubMed ID: 33328740
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial.
Hu Y; Qin T; Li S; Zhang T; Xue J
Front Oncol; 2020; 10():1589. PubMed ID: 32984021
[TBL] [Abstract][Full Text] [Related]
5. Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial.
Hou Z; Zhu K; Yang X; Chen P; Zhang W; Cui Y; Zhu X; Song T; Li Q; Li H; Zhang T
Ann Transl Med; 2020 Sep; 8(17):1047. PubMed ID: 33145266
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study.
Liu C; Xing W; Si T; Yu H; Guo Z
Oncotarget; 2017 Nov; 8(59):100734-100745. PubMed ID: 29246017
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.
Xia Y; Tang W; Qian X; Li X; Cheng F; Wang K; Zhang F; Zhang C; Li D; Song J; Zhang H; Zhao J; Yao A; Wu X; Wu C; Ji G; Liu X; Zhu F; Qin L; Xiao X; Deng Z; Kong X; Li S; Yu Y; Xi W; Deng W; Qi C; Liu H; Pu L; Wang P; Wang X
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35379737
[TBL] [Abstract][Full Text] [Related]
8. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Hu Y; Zhou M; Tang J; Li S; Liu H; Hu J; Ma H; Liu J; Qin T; Yu X; Chen Y; Peng J; Zou Y; Zhang T; Xue J
Clin Cancer Res; 2023 Oct; 29(20):4088-4097. PubMed ID: 37556120
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open-label, single-arm, prospective, multi-center phase I trial.
Li G; Shu B; Zheng Z; Yin H; Zhang C; Xiao Y; Yang Y; Yan Z; Zhang X; Yang S; Li G; Dong J
Front Oncol; 2022; 12():1051916. PubMed ID: 36505833
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
12. An exploratory clinical trial of apatinib combined with intensity-modulated radiation therapy for patients with unresectable hepatocellular carcinoma.
Qiu H; Ke S; Cai G; Wu Y; Wang J; Shi W; Chen J; Peng J; Yu B; Chen Y
Cancer Med; 2023 Jan; 12(1):213-222. PubMed ID: 35633045
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study.
Zheng Z; Liu Z; Zhang H; Guo X; Jia X; Wang J; Meng L; Xin Y; Jiang X
Front Pharmacol; 2022; 13():894016. PubMed ID: 35656302
[No Abstract] [Full Text] [Related]
15. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Sun T; Chen L; Kan X; Ren Y; Cao Y; Zhang W; Lu H; Zheng C
J Oncol; 2022; 2022():1255133. PubMed ID: 35356254
[TBL] [Abstract][Full Text] [Related]
16. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
17. The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
Mähringer-Kunz A; Steinle V; Kloeckner R; Schotten S; Hahn F; Schmidtmann I; Hinrichs JB; Düber C; Galle PR; Lang H; Weinmann A
PLoS One; 2021; 16(5):e0249426. PubMed ID: 33961627
[TBL] [Abstract][Full Text] [Related]
18. Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study.
He W; Liao L; Hu D; Li B; Wang C; Qiu J; Liao Y; Liu W; Yang Z; Zhang Y; Yuan Y; Li K; Yuan Y; Zheng Y
Ann Transl Med; 2020 Aug; 8(16):1000. PubMed ID: 32953800
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.
Zhang B; Qi L; Wang X; Xu J; Liu Y; Mu L; Wang X; Bai L; Huang J
Cancer Commun (Lond); 2020 Dec; 40(12):711-720. PubMed ID: 33314747
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma.
Li Z; Chen Q; Zhang W; Si G; Li J; Jiao D; Han X
Can J Gastroenterol Hepatol; 2021; 2021():5565793. PubMed ID: 34458205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
